|
Dec 4
|
Amylyx Pharmaceuticals Announces Publication of Data Showing the Effect of AMX0035 on Plasma Neuroinflammatory Biomarkers in ALS
|
|
Nov 29
|
Amylyx Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
|
|
Nov 28
|
Amylyx Pharmaceuticals Appoints Camille L. Bedrosian, MD, as Chief Medical Officer
|
|
Nov 27
|
RELYVRIO® and AMX0114 Data to be Presented at 34th International Symposium on ALS/MND
|
|
Nov 12
|
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Q3 2023 Earnings Call Transcript
|
|
Nov 10
|
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Stock's 34% Dive Might Signal An Opportunity But It Requires Some Scrutiny
|
|
Nov 10
|
Q3 2023 Amylyx Pharmaceuticals Inc Earnings Call
|
|
Nov 9
|
Amylyx Crashes 32% On A Quarterly Report That Doesn't Bode Well For 2024
|
|
Nov 9
|
Amylyx Pharmaceuticals Inc (AMLX) Reports Strong Q3 2023 Earnings with Significant Revenue Growth
|
|
Nov 9
|
Amylyx Pharmaceuticals Reports Third Quarter 2023 Financial Results
|
|
Nov 4
|
12 Best Small-Cap Biotech Stocks with Massive Potential According to Hedge Funds
|
|
Nov 2
|
Amylyx Pharmaceuticals, Inc. (AMLX) Earnings Expected to Grow: What to Know Ahead of Q3 Release
|
|
Nov 2
|
Amylyx Pharmaceuticals to Report Third Quarter 2023 Financial Results on November 9, 2023
|
|
Sep 20
|
Marinus Pharmaceuticals (MRNS) Soars 19.9%: Is Further Upside Left in the Stock?
|
|
Aug 14
|
Amylyx's new ALS drug has turned a profit for six months straight
|
|
Aug 13
|
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Q2 2023 Earnings Call Transcript
|
|
Aug 11
|
Q2 2023 Amylyx Pharmaceuticals Inc Earnings Call
|
|
Aug 10
|
Amylyx Pharmaceuticals, Inc. (AMLX) Surpasses Q2 Earnings and Revenue Estimates
|
|
Aug 10
|
Amylyx Pharmaceuticals Reports Second Quarter 2023 Financial Results
|